Bio Protocol crypto experienced a surge of 25% on Tuesday, reaching a market cap of $217.58 million after positive announcements regarding clinical trials for brain health treatments. The protocol recently secured funding to support human trials for a new supplement, Percepta. This news fueled increased trading activity, resulting in a 720.24% increase in daily trading volume exceeding $443 million. Several key updates contributed to the token’s momentum: the launch of Bio Markets with real-time DeSci analytics and BioAgent trading, significant staking initiatives including a rise in staked BIO tokens to 125 million ($BIO) representing 3.5% of its circulating supply, and funding for a clinical trial for Percepta. These developments solidify the connection between BIO crypto and the success of the brain health supplement.